Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
Emerging evidence indicates that thromboembolic complications are a key determinant of inhospital mortality of patients with COVID-19. Prophylactic anticoagulation therapy is an important component of inhospital management of patients with COVID-19. Considering that millions of patients worldwide ar...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer Health/LWW
2020-01-01
|
| Schriftenreihe: | Cardiology Plus |
| Schlagworte: | |
| Online-Zugang: | http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2020;volume=5;issue=4;spage=171;epage=174;aulast=Cai |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
